| Literature DB >> 29941029 |
Xiao-Chuan Li1, Mao-Sheng Wang1, Wei Liu1, Cheng-Fan Zhong1, Gui-Bin Deng1, Shao-Jian Luo1, Chun-Ming Huang2.
Abstract
BACKGROUND: Cell therapy for the treatment of intervertebral disc degeneration (IDD) faces serious barriers since tissue-specific adult cells such as nucleus pulposus cells (NPCs) have limited proliferative ability and poor regenerative potential; in addition, it is difficult for exogenous adult stem cells to survive the harsh environment of the degenerated intervertebral disc. Endogenous repair by nucleus pulposus mesenchymal stem cells (NPMSCs) has recently shown promising regenerative potential for the treatment of IDD. Notochordal cells (NCs) and NC-conditioned medium (NCCM) have been proven to possess regenerative ability for the treatment of IDD, but this approach is limited by the isolation and passaging of NCs. Our previous study demonstrated that modified notochordal cell-rich nucleus pulposus (NC-rich NP) has potential for the repair of IDD. However, whether this can protect NPMSCs during IDD has not been evaluated.Entities:
Keywords: Intervertebral disc degeneration; Notochordal cell-rich nucleus pulposus explants; Nucleus pulposus mesenchymal stem cells; Senescence; TNF-α
Mesh:
Substances:
Year: 2018 PMID: 29941029 PMCID: PMC6019307 DOI: 10.1186/s13287-018-0919-9
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Fig. 1Process of harvesting notochordal cell (NC)-rich nucleus pulposus (NP) explants model and grouping. Rabbit NP tissue from L4/5, L5/6, or L6/7 IVDs were harvested and partially digested to harvest NC-rich NP for the explant model. Human nucleus pulposus mesenchymal stem cells (NPMSCs), incubated in 24-well transwell inserts, were cultured in serum-free medium for 24 h. Subsequently, samples were divided into three groups in triplicate as follows: group 1 was treated as the control, group 2 was treated with 10 ng/ml tumor necrosis factor (TNF)-α, and group 3 was treated with 10 ng/ml TNF-α and NC-rich NP as the coculture group. After 7 days of culture, NC-rich NP explants and NPMSCs were harvested for further analysis
Fig. 2Isolation and identification of human nucleus pulposus mesenchymal stem cells (NPMSCs). a Flow diagram of the separation and purification of NPMSCs from human nucleus pulposus (NP) tissue. The harvested NPMSCs at passage 3 displayed a spindle shape in spiral or parallel arrangement. b Identification of the stem cell surface molecular profile indicated that the harvested cells were negative for HLA-DR, CD34, and CD45 expression, but positive for CD73, CD90, and CD105 expression. Osteogenic differentiation of NPMSCs (c) and control cells (f) stained with alizarin red after 3 weeks. Adipogenic differentiation of NPMSCs (d) and control cells (g) stained with oil red O after 3 weeks. Chondrogenic differentiation of NPMSCs (e) and control cells (h) stained with Alcian blue after 3 weeks. Identification of chondrogenic microspheres by alcian blue (i) and toluidine blue (j) staining, respectively. Higher mRNA expression of collagen IIα1 and aggrecan was observed in NPMSCs after a 4-week induction (k). Quantitative mRNA analysis of the expression of markers of the three lineages in both induced and control cells showed higher mRNA expression levels of all osteogenic (k), adipogenic (l), and chondrogenic (m) differentiation-related gene expression
Primers for target genes
| Gene | Forward sequence | Reverse sequence |
|---|---|---|
| Collagen Iα1 | 5′-CCTGGAAAGAATGGAGATGATG-3′ | 5′-ATCCAAACCACTGAAACCTCTG-3′ |
| Collagen IIα1 | 5′-GGTAAGTGGGGCAAGACTGTTA-3′ | 5′-TGTTGTTTCTGGGTTCAGGTTT-3′ |
| Sox-9 | 5′-GCCTCTACTCCACCTTCACCTA-3′ | 5′-GCTGTGTGTAGACAAGTTGTT-3′ |
| Aggrecan | 5′-GTCAGATACCCCATCCACACTC-3′ | 5′-CATAAAAGACCTCACCCTCCAT-3′ |
| LPL | 5’-TCCGCGTGATTGCAGAGAGAG-3′ | 5’-TGCTGCTTCTTTTGGC |
| PPAR-2 | 5’-CGAGGGCGATCTTGACAGGAA − 3′ | 5’-CAGGGGGGTGATGT |
| RUNX-2 | 5’-ACGACAACCGCACCATGGT-3’ | 5’-CTGTAATCTGACTCT |
| ALP | 5’-TGGAGCTTCAGA AGCTCAACACCA-3’ | 5’-ATCTCGTTGTCTGAG |
| p16 | 5′-ACCAGAGGCAGTAACCATGC-3′ | 5′-TGATCTAAGTTTCCCGAGGTTT-3′ |
| p21 | 5′-TTAGCAGCGGAACAAGGAGT-3′ | 5′-CGTTAGTGCCAGGAAAGACA-3′ |
| p53 | 5′-TAGTGTGGTGGTGCCCTATG-3′ | 5′-CCAGTGTGATGATGGTGAGG-3′ |
| IL-6 | 5′-ATGCCTGACCTCAACTCCACT-3′ | 5′-GCCACCCAGCTGCAAGATTTC-3′ |
| ADAMTS-5 | 5′-GGACCTACCACGAAAGCAGATC-3′ | 5′-GCCGGGACACACGGAGTAC-3′ |
| MMP-13 | 5′-TGGAAGGATGCCTTTTTTTCTC-3′ | 5′-CACCCTCCCCAAGTATCAATAGG-3′ |
| Brachyury | 5′-AGACAGCCAGCAATCTG-3′ | 5′-TGGAGGGAAGTGAGAGG-3′ |
| KRT18 | 5′-GGACAGCTCTGACTCCAGGT-3′ | 5′-AGCTTGGAGAACAGCCTGAG-3′ |
| HIF-1α | 5′-GAAGTGTACCCTAACTAGCCGAGGA-3′ | 5′-TGAATGTGGCCTGTGCAGTG-3′ |
| CA12 | 5′-CTGTGGGTCCAGCTTTGGAA-3′ | 5′-TGCCATGCAGCAGAGTTAGGAG-3′ |
| FOX1 | 5′-CACACAGGAATTCTGCTGAGGT-3′ | 5′-TGATTGGTCTCACATGTTTGCT-3′ |
| PAX1 | 5′-AACTTGGCTTAAATCTCTGCTCCAC-3′ | 5′-GCATTGAAGGCTACATTTCACAGAC-3′ |
| β-actin | 5′-GTGGGGCGCCCCAGGCACCA-3′ | 5′-CTTCCTTAATGTCAC |
Fig. 3Notochordal cell (NC) viability and markers in NC-rich nucleus pulposus (NP) explant model after 7 days of culture. The viability of NCs in NC-rich NP explants derived from L4/5, L5/6, or L6/7 IVDs is shown, based on similar live cell percentages (a,b). For real-time PCR, brachyury (c) and keratin 18 (KRT18) (d) were tested in the three segments of NC-rich NP explants, which were found to be similarly expressed but significantly upregulated compared with expression in NCs. All data are expressed as mean ± standard deviation; n = 3. CAM calcein-AM, PI propidium iodide
Fig. 4Coculturing tumor necrosis factor (TNF)-α-treated nucleus pulposus mesenchymal stem cells (NPMSCs) with notochordal cell (NC)-rich nucleus pulposus (NP) explants attenuates cell senescence. Morphological changes in NPMSCs with different test compounds, as detected by inverted microscopy, scanning electron microscopy, and senescence-associated β-galactosidase (SA-β-gal) staining after 7 days of culture (a). Positive staining for SA-β-gal was compared in different groups (b). Meanwhile, real-time PCR analysis of p16 (c), p21 (d), and p53 (e) mRNA expression was performed. Furthermore, the expression of senescence-associated proinflammatory cytokines interleukin (IL)-6 (f) and extracellular proteases MMP-13 (g) and ADAMTS-5 (h) was tested. Data are expressed as mean ± SD values (n = 4). *p < 0.05
Fig. 5Coculturing tumor necrosis factor (TNF)-α-treated nucleus pulposus mesenchymal stem cells (NPMSCs) with notochordal cell (NC)-rich nucleus pulposus (NP) explants significantly promotes proliferation. After NPMSCs were treated with different test compounds for 7 days, cell proliferation assays (resulting in optical density (OD) values) were performed. Proliferation in TNF-α-treated NPMSCs was significant decreased on days 1, 3, 5, and 7, whereas coculturing with NC-rich NP explants attenuated the inhibitory effects of TNF-α on NPMSC proliferation, with significant differences on days 5 and 7 (a). In addition, NPMSC numbers were similar but were associated with a significant decline on days 5 and 7; however, coculturing with NC-rich NP explants attenuated this trend on day 7 (b). Data are expressed as mean ± SD values (n = 4). *P < 0.05
Fig. 6Coculturing tumor necrosis factor (TNF)-α-treated nucleus pulposus mesenchymal stem cells (NPMSCs) with notochordal cell (NC)-rich nucleus pulposus (NP) explants enhances the expression of NP cell markers. Representative image of immunofluorescence staining (a) and quantification analysis of carbonic anhydrase 12 (CA12) protein expression in the three groups after 7 days of culture (b). Western blot analysis (c) and densitometric quantification (d) of CA12 proteins with different treatments. The gene expression levels of CA12, FOXF1, PAX1, and HIF-1α in NPMSCs were compared among different groups after 7 days of culture (e–h). All data are expressed as mean ± SD values (n = 4). *P < 0.05
Fig. 7Coculturing tumor necrosis factor (TNF)-α-treated nucleus pulposus mesenchymal stem cells (NPMSCs) with notochordal cell (NC)-rich nucleus pulposus (NP) explants increases the expression of matrix macromolecules. Representative image of immunofluorescence staining (a) and quantification analysis of collagen II protein expression in the three groups after 7 days of culture (b). Glycosaminoglycan (GAG)/DNA ratio in NPMSCs treated with different test compounds for 7 days (c). Western blot analysis (d) and densitometric quantification (e) of collagen II proteins in three groups. The mRNA expression levels of aggrecan, Sox-9, Col1α1, and Col2α1 in NPMSCs were compared within different groups after 7 days of culture (f–i). All data are expressed as mean ± SD values (n = 4). *P < 0.05